Vaxart Q3 EPS $(0.11) Beats $(0.18) Estimate, Sales $2.10M Beat $100.00K Estimate
Portfolio Pulse from mahesh@benzinga.com
Vaxart (NASDAQ:VXRT) reported Q3 losses of $(0.11) per share, beating the analyst consensus estimate of $(0.18) by 38.89%. This is a 52.17% increase over losses from the same period last year. The company also reported quarterly sales of $2.10 million, beating the analyst consensus estimate of $100.00 thousand by 2.00K percent.
November 02, 2023 | 8:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vaxart's Q3 earnings beat analyst estimates, which could lead to a positive market reaction.
Vaxart's Q3 earnings beat analyst estimates, which is typically seen as a positive sign by investors and could lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100